Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression: (Consensus Statement)
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide expert recommendations for the safe and effective application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD). PARTICIPANTS: Participants included a group of 17 expert clinicians and researchers with expertise in the clinical application of rTMS, representing both the National Network of Depression Centers (NNDC) rTMS Task Group and the American Psychiatric Association Council on Research (APA CoR) Task Force on Novel Biomarkers and Treatments. EVIDENCE: The consensus statement is based on a review of extensive literature from 2 databases (OvidSP MEDLINE and PsycINFO) searched from 1990 through 2016. The search terms included variants of major depressive disorder and transcranial magnetic stimulation. The results were limited to articles written in English that focused on adult populations. Of the approximately 1,500 retrieved studies, a total of 118 publications were included in the consensus statement and were supplemented with expert opinion to achieve consensus recommendations on key issues surrounding the administration of rTMS for MDD in clinical practice settings. CONSENSUS PROCESS: In cases in which the research evidence was equivocal or unclear, a consensus decision on how rTMS should be administered was reached by the authors of this article and is denoted in the article as "expert opinion." CONCLUSIONS: Multiple randomized controlled trials and published literature have supported the safety and efficacy of rTMS antidepressant therapy. These consensus recommendations, developed by the NNDC rTMS Task Group and APA CoR Task Force on Novel Biomarkers and Treatments, provide comprehensive information for the safe and effective clinical application of rTMS in the treatment of MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repetitive transcranial magnetic stimulation (rTMS) is an effective method used in clinical practice for treating patients with MDD. 408”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [408]
In the citing paper
“Most clinical rTMS treatments for MDD occur daily (one rTMS session per day) and are applied using scalp-based targeting of DLPFC. These standard treatments are only modestly effective, even in the general MDD population (17, 24–31).”
In the citing paper
“rTMS of the left side of the dorsolateral prefrontal cortex (DLPFC) at 10 Hz is a well-tolerated, evidence-based treatment for TRD.5”
In the citing paper
“While this intensity is consistent with current recommendations for standard rTMS,5 there is no current consensus on the optimal intensity for TBS and other studies have used lower intensities.12”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367
NON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Wassermann, E. M. (1998) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/s0168-5597(97)00096-8 · Cited by 2,293
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910
Self-citationUsing the International 10-20 EEG System for Positioning of Transcranial Magnetic Stimulation
Herwig, U., Satrapi, P., & Schönfeldt-Lecuona, C. (2003) · Brain Topography · doi:10.1023/b:brat.0000006333.93597.9d · Cited by 1,098
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“…magnetic stimulation device package insert as well as in the US Food and Drug Administration (FDA) 510k application material. b In the study by George et al,10 patients underwent head magnetic resonance imaging with fiducials (vitamin E capsules), which resulted in 33.2% of patients having…”
BackgroundSelf-citation
Cited by
Items 601–690 of 690
Taylor, D. L., Caulfield, K. A., & Mischel, N. (2025) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2025.04.001
Yip, A. G., Copersino, M. L., Halko, M. A., Morales, O., Bolton, P., Brown, J. C., Ressler, K. J., & Seiner, S. J. (2025) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2025.100172
Self-citationJones, T., Shalom, M., Chalamgari, A., Gold, J. L., Zomalan, B., Patel, S., Munjal, V., Khan, M. F., Mao, Y., Gendreau, J. L., et al. (2025) · Cureus · doi:10.7759/cureus.85156 · Cited by 1
Dols, A., Biemans, T., Coomans, C., van Eijndhoven, P., Dalhuisen, I., van der Werf, Y. D., Vriend, C., Gomes, E. S. A., Sack, A. T., Schuhmann, T., et al. (2025) · JMIR Research Protocols · doi:10.2196/70121
“Randomized controlled trials (RCTs) have consistently demonstrated the efficacy and safety of rTMS in TRD, with remission rates of approximately 25% [4,6-8].”
The clinical efficacy of heart rate as a biomarker for TMS
Heck, K., Ferguson, J., Sege, C. T., Huffman, S., Brown, T. R., & George, M. S. (2025) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2025.100180 · Cited by 1
Self-citationBruno, A., Dolcetti, E., Annovazzi, P. O. L., Clerico, M., Cocco, E. E., Conte, A., Marfia, G. A., Salvetti, M., Tomassini, V., Clerici, V. T., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1557335 · Cited by 1
“We know from literature that stimulation by intermittent-theta burst stimulation (iTBS) of orbito-frontal cortex in patients with depressive disorder shows ef fi cacy in recovering from acute phases (80).”
Transcranial Magnetic Stimulation for Substance Use Disorders: Ethical Considerations
Mehta, D. D., Hiebert, M., Tang, V. M., Ward, H. B., & George, T. P. (2025) · Advances in neuroethics · doi:10.1007/978-3-031-92401-9_14
An Introduction to TMS and Neuroethics
D’Alessandro, A., Young, J. R., & Dubljević, V. (2025) · Advances in neuroethics · doi:10.1007/978-3-031-92401-9_1
Bal, F. (2025) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaf069
Qian, A., Wang, S., Kong, G., Wu, G., Meng, Z., Daskalakis, A. A., Tang, Y., & Liu, F. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120023 · Cited by 1
Transcranial magnetic stimulation for treatment-resistant depression
Batail, J.-M. V., Narita, Z. C., Coetzee, J. P., Brown, J. C., Nejad, R., Stimpson, K. H., Phillips, A., Cole, E. J., Sahlem, G. L., & Williams, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00017-7 · Cited by 1
Neurostimulation may herald a new treatment for depression
Lefebvre, J. (2020) · doi:10.64628/aap.ndpgygnta
Sciatic Nerve Stimulation Mitigates Depression‐Like Behaviors and Memory Deficits in Stressed Mice
Tien, C., Chen, P., Hsiao, Y., Wong, C., Wu, M., Chen, Y., Huang, K., Lee, P., Chang, K., Hsu, H., et al. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70091
Diagnosis and Treatment of Epilepsy Comorbidities
Han, Y., Gu, Y., Yan, Y., Jiang, G., & Tian, X. (2025) · Springer eBooks · doi:10.1007/978-981-96-8520-2_7
Khan, H., Ayala, L., & Parise, C. A. (2025) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2025.100288 · Cited by 1
Durade-Replat, P.-E., Floccia, M., Philippe, A., & Bienvenu, T. (2025) · L Encéphale · doi:10.1016/j.encep.2025.05.008
Sun, G., Shen, Z., Wang, M., & Zhang, X. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1615403 · Cited by 1
Elektromagnetfeldtherapie: Welchem System darf man vertrauen?
Kafka, W. A. (2025) · Springer eBooks · doi:10.1007/978-3-662-68956-1_30
Repetitive Transcranial Magnetic Stimulation in Dementia
Mikellides, G., Jomeh, A. A. E., Roy, E., & Kyriazis, M. (2025) · Current Aging Science · doi:10.2174/0118746098392580251003064940
Ma, L., Ma, X., Huang, W., Wang, J., Yue, S., Xu, L., Ma, X., Xiong, Y., Zhang, J., & Hu, W. (2025) · Psychoradiology · doi:10.1093/psyrad/kkaf034 · Cited by 1
“In accordance with transcranial magnetic stimulation treatment guidelines (McClintock et al. , 2018 ), the rTMS parameters were as follows: the treatment was administered once daily for 10 consecutive days, with an intensity set at 100% of the motor threshold.”
Chen, L., Thomas, E., & Cerins, A. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-26602-7.00030-0
Farfan, C. H. V., Virto, C., & Tafet, G. E. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101154 · Cited by 1
“…for such patients. rTMS, approved by the U.S. Food and Drug Administration for treatment-resistant depression (TRD), typically targets the left dorsolateral prefrontal cortex (L-DLPFC) and has demonstrated safety and efficacy in this context (Lefaucheur et al., 2014; McClintock et al., 2018).”
Konikkou, K., Isdahl-Troye, A., Sikki, M., & Fanti, K. A. (2025) · Brain Sciences · doi:10.3390/brainsci15121328
“This technology is commonly used in clinical studies on emotional disorders, such as depression [38–40] and anxiety [41,42], but also it showed promising effects in the management of substance and behavioral addiction [43], as well as to symptoms related to borderline personality disorder [44,45]…”
Johnson, J., Arellano, P., Chang, A. M., Hernandez, J. E. C., Sie, R., Putnam, J., Lü, Y., Jacobson, E. M., & Peterson, K. A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120878 · Cited by 1
Increased Aperiodic Exponents Track Depression Symptom SeverityPreprint
Libowitz, M. R., Sun, W., Rabinovich, R. J., Du, J., Campbell, J. M., Cowan, R. L., Shahdoust, N., Price, T. A., Davis, T. S., Buckner, R. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.694966
Ørbo, M. C., Grønli, O., Larsen, C., Vangberg, T. R., Friborg, O., Turi, Z., Mittner, M., Csifcsák, G., & Aslaksen, P. M. (2023) · Figshare · doi:10.6084/m9.figshare.24234191
Tao, Y., Liang, Q., Zhang, F., Guo, S., Fan, L., & Zhao, F. (2024) · Figshare · doi:10.6084/m9.figshare.26695758
Tao, Y., Liang, Q., Zhang, F., Guo, S., Fan, L., & Zhao, F. (2024) · Figshare · doi:10.6084/m9.figshare.25449034
Tao, Y., Liang, Q., Zhang, F., Guo, S., Fan, L., & Zhao, F. (2024) · Figshare · doi:10.6084/m9.figshare.25449139
Tao, Y., Liang, Q., Zhang, F., Guo, S., Fan, L., & Zhao, F. (2024) · Figshare · doi:10.6084/m9.figshare.26695764
Tao, Y., Liang, Q., Zhang, F., Guo, S., Fan, L., & Zhao, F. (2024) · Figshare · doi:10.6084/m9.figshare.26695755
Tao, Y., Liang, Q., Zhang, F., Guo, S., Fan, L., & Zhao, F. (2024) · Figshare · doi:10.6084/m9.figshare.26695761
Martín-López, E., Ruiz-Ramos, A., Rosario-Lozano, M. P., & Blasco‐Amaro, J. A. (2025) · doi:10.52766/cuvk5385
TMS as a Tool for Mapping the Dynamic Properties of Language in the Brain
Kaur, H., Grant, G. A., & Baumer, F. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009202336.006
Neuroimaging Studies of Brain and Language
Andrews, E., & Kiran, S. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009202336.003
Non-implantable neuromodulation therapies compared to conventional treatments for major depression
Lima, V. F. B., Silva, V. A., Pelosof, R., Malfatti, V., Cretaz, E., Vidal, K. S. M., Brunoni, A. R., & Cavenaghi, V. B. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2626459
“The American Psychiatric Association recommends careful screening for contraindications (e.g. ferromagnetic implants, epilepsy, unstable medical conditions) and individualized risk-benefit assessment [79].”
Pustay, D., Patel, V., Ulisse, K., & Aromin, J. T. (2026) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2026.2623198
Repetitive transkranielle Magnetstimulation bei unipolarer Depression
Kavakbasi, E., Koelkebeck, K., & Steiner, K. M. (2026) · Der Nervenarzt · doi:10.1007/s00115-026-01942-x
Wang, S., Wang, W., Yao, M. Y., Cui, J., Zong, B., Liu, J., Guo, D., & Li, L. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07943-z
Li, H., Dong, L., Cao, L., Tang, Z., Liu, T., Liu, J., Zhang, X., & Zhang, H. (2026) · European journal of medical research · doi:10.1186/s40001-026-04117-1
Distinct Biotypes of Visual Perception in Major Depressive Disorder
Cai, Z., Hu, X., Li, Y., Lin, Z., Li, Y., Cai, Y., Xu, T., Jia, K., Han, J., Tan, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.74882
“While cognitive impairment is a known contributor to poor functional outcomes and reduced efficacy of first-line antidepressants [ 5, 17 ], non-pharmacological interventions like repetitive TMS (rTMS) have demonstrated promising efficacy in ameliorating these deficits [ 61–64 ].”
Xu, R., Hu, J., Cao, X., He, Y., Wang, Q., Zhu, J., Yu, C., Chen, Y., & Guo, C. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-116530
“Orthopaedic metallic implants located distal to the stimulation site (eg, internal fixation devices in the foot or ankle) may be permitted, 49 provided that the implant is non-ferromagnetic, securely fixed and anatomically remote from the stimulation area.”
Niu, W. L., Cline, C. C., Daniel, B. L., & Leuze, C. W. (2026) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2026.3679091
“For example, repetitive transcranial magnetic stimulation (rTMS) can require five sessions per week for four to six weeks [20, 24, 29].”
Cosker, E. (2021) · theses.fr (ABES) · doi:10.70675/b38758e0zd393z4e74za68ez893e1ec6706c · Cited by 1
Li, Y., Chan, V. K. Y., Jit, M., Cheng, F. W. T., Yiu, H. H. E., Bishai, D. M., Craig, D., Chan, E. W., Chan, S. S. M., & Li, X. (2026) · PLoS Medicine · doi:10.1371/journal.pmed.1005047 · Cited by 1
Wang, W., Zhou, S., Wang, Y., Huang, Y., Ni, H., & Yao, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1832192
“This stimulation paradigm has been shown to effectively modulate DLPFC excitability, thereby downregulating hyperactivity in subcortical regions such as the amygdala via the pre-frontal-limbic pathway, ultimately alleviating anxiety symptoms (39, 42).”
Vélez, F. G. S., Cedeno-Bruzual, M., Gutiérrez, M. Z., Pena, D. M., Ballard, C., Kong, J. S., Pinaffi‐Langley, A. C. D. C., Owens, C. D., TucsekCardon, Z., Szarvas, Z., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1778992 · Cited by 1
“It became a widely used clinical tool after FDA approval in 2008, for the treatment of medication-refractory major depressive disorder (McClintock et al., 2018).”
Rodríguez, D. A. A., Espinosa, M. F. G., Morales, G. O., Mora, N. M., & Medina, F. E. O. (2026) · Cureus · doi:10.7759/cureus.108454
“In cases of moderate to severe non-psychotic depression, rTMS may be considered before more invasive procedures, especially in outpatient settings [2].”
InfluentialQiu, D., Liu, X., Lu, W., Liu, F., & Wang, W. (2026) · Brain Conflux · doi:10.71321/vah93v44
“Early studies demonstrated that single-pulse TMS (sTMS) can suppress CSD, highlighting its potential in treating migraine with aura [9-11].”
Prescribed Interventions to Reduce Depression
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_22
Keshavarzi, A., Arandi, S. Z., Ahmadpanah, M., Haghighi, M., Jahangard, L., Soltanian, A., Hormoz, N., & Brand, S. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.05.010
Rakic, L., Tas, F. Q., Chen, M., Tendolkar, I., van Eijndhoven, P., Lange, J. D.-D., Hofmeijer-Sevink, M. K., Hoogendoorn, A. W., & Rhebergen, D. (2026) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70110
“This aligns with current adult protocols, such as Dutch and FDA guidelines, that primarily advise rTMS in cases of TR-MDD [60, 61].”
Why health authorities should endorse rTMS for treatment-resistant depression
Batail, J.-M. V., Gaillard, R., Haffen, É., Poulet, E., Sauvaget, A., Szekely, D., Brunelin, J., Bulteau, S., Bubrovszky, M., Smadja, J., et al. (2026) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2026.100321
王, 振. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662231
Asay, C., & Espiridion, E. D. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.06.025
Pedraz-Petrozzi, B., Wilkening, J., Ziegler, N., Arns, M., Sartorius, A., & Goya‐Maldonado, R. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111814
dDual-target rTMS treatment for adolescent depression with headache: a case report
Sun, G., Yin, Y., & Yuan, Y. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08106-w
“The accelerated schedule employed here may have induced more robust or rapidly consolidating synaptic plasticity, potentially through cumulative effects on neurotrophic signaling and glutamatergic neurotransmission [58].”
Gregory, D. F., Sun, I., Teferi, M., Gura, H., Patel, M., Casalvera, A., Chandrashekar, S., Lynch, K. G., Schultz, D. H., Jeyapratap, A., et al. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1314 · Cited by 1
“This limits precision and may reduce clinical impact ( McClintock et al., 2018).”
Ørbo, M. C., Grønli, O., Brochs, M. S., Friborg, O., Vangberg, T. R., Selaas, R., Larsen, C., Mittner, M., Turi, Z., Csifcsák, G., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.21262 · Cited by 1
Increased Aperiodic Exponents Track Depressive Symptom Severity in Refractory Epilepsy
Libowitz, M. R., Sun, W., Rabinovich, R. J., Du, J., Campbell, J. M., Cowan, R. L., Shahdoust, N., Price, T. A., Davis, T. S., Buckner, R. L., et al. (2026) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2026.06.017 · Cited by 2
Kılıç, C., Öztürk, S., Ceyran, B., Ozturk, S. K., Kocabıyık, A. M., Sabancı, P. A., & Aydın, E. P. (2026) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2026.112284
Viegas, C., Ranjbar, S., Mall, J., Vandel, P., von Gunten, A., Moyano, B. P., & Swierkosz-Lenart, K. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1794892
Oliver, L. D., Blumberger, D. M., Deng, Z., Hawco, C. S., Dickie, E. W., Gallucci, J., Jeyachandra, J., Mansour, S., Hare, S., Gold, J. M., et al. (2026) · Brain stimulation · doi:10.1016/j.brs.2026.103172
“Before initiating treatment, each participant’s resting motor threshold (RMT) of the hand region of the motor cortex was determined in accordance with standard clinical practice [59,60].”
rTMS for treatment resistant depression – a single center community experience
Jacques, F. H., Godin, C., Rabia, N., & Apedaile, B. E. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1892766
Herrmann, M. J. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21372-4.00024-x
Chen, H., Xu, D., Wang, W., Luo, X., Jiang, X., Wan, N., Wei, Y., Wang, T., Zhang, L., Li, X., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355676 · Cited by 1
Ni, J., Qiao, M.-X., Lin, Y.-G., Yu, H., & Li, T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.08.001
Roh, D. D. (2026) · International Journal of Brain Stimulation · doi:10.67731/ijbs.1.107
Karimi, A., Zakeri, H., Radmehr, M., Moalemi, S., & Pedramfard, P. (2026) · Sensory Neuroscience · doi:10.1002/sen2.70040
Ma, C.-H., Chen, K.-Y., Chen, T.-T., Huang, W., & Gau, S. S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122388
Zhang, O., Zhou, C., Zhang, C., Wang, Q., Fan, L., & Han, X. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1925491
Zhao, Y., Mo, Q., Liu, Y., Chen, X., Zhao, Q., Wang, H., Yan, Z., Cao, L., & Zhao, G. (2026) · Brain and Behavior · doi:10.1002/brb3.71722
Noda, Y. (2026) · Expert Review of Medical Devices · doi:10.1080/17434440.2026.2717170
“Integration with pharmacotherapy, psychotherapy, or behavioral interventions represents an additional frontier, enabling coordinated modulation of neural circuits across multiple levels of organization [25,290].”
Wang, Z., Sun, J., & Li, W. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-026-10632-y
Takahashi, S., Eto, M., Hata, M., Shinosaki, K., & Ikeda, M. (2026) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70404
Cognitive state dependent enhancement of cognitive control with transcranial magnetic stimulation
McInnes, A. N., Pipia, V. L., Maynard, K. L., Kalender, G., & Widge, A. S. (2026) · Brain stimulation · doi:10.1016/j.brs.2026.103227 · Cited by 1
Elkrief, L., Gonzalez, B. E., Boubekri, S., Do, A., Trottier-Duclos, F., Miron, J., Garel, N., Briganti, G., Lespérance, P., & Wade, B. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122602
Pàmies‐Vilà, R., Mallol-Bordas, L., Pascual‐Rubio, V., & Fabregat‐Sanjuan, A. (2026) · Brain and Behavior · doi:10.1002/brb3.71805
“This area is frequently selected for interventions such as repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder (Avery et al. 2006 ; McClintock et al. 2018 ; Seibt et al. 2015 ).”
Tay, Y. H., & Thng, E. W. C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1924135
“Our standardised use of stimulation protocols targeting solely the left DLPFC (approximated by the F3 position) further provides an opportunity to evaluate outcomes using a consistent treatment target (4, 5).”
Bilal, M., Kumari, M., Farooq, S. Z., Sajjad, F., Ullah, M. S., Akif, M., Iftikhar, S., Saddique, M. N., & Nazari, M. J. (2026) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70427
“22 The broadly favorable findings in several parallel ‐ group trials contrast with the nonspecific improvement in the early crossover trial and may partly explain the observed heterogeneity.”
Adler, E., Blumberger, D. M., Lenze, E. J., Brown, P. J., Karp, J. F., Lavretsky, H., Rhee, T. G., Mulsant, B. H., & Kaster, T. S. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260398
Ersungur, E. B., Poyraz, B. Ç., Arslan, S., & Kargın, O. A. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122635
Holst, L., Carmo, A. L., Speed, M. S., Petersen, M. B. K., Pimenta, S., Kølbæk, P., & Gasse, C. (2026) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2026.2744718
“%) was lower than the 40%–55% typically reported in controlled trials, likely reflecting the clinical complexity of the cohort, including high rates of recurrent depression, psychiatric comorbidity, and prolonged episode duration [8,9,40].”
Ali, A. M. S., Gorter, M., Zakaria, R., Jenkinson, M. D., Frank, B., Klein, M., Hamer, P. C. D. W., & Douw, L. (2026) · Brain stimulation · doi:10.1016/j.brs.2026.103226
Brain Stimulation as a Treatment for Apathy: A Scoping Review of Effects and Safety
Grewal, P., Seidman, M. B., Chasen, J., Lench, D. H., Dickens, I., Brennan, E. A., Rodriguez‐Porcel, F. E., Kindred, J. H., George, M. S., Kautz, S., et al. (2026) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20250297
Self-citationTu, J., Wei, S., Shi, Y., Zhou, S., Zhi, T., Yao, M., & Ni, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1923206
“All personnel have been trained in device operation, coil positioning, and motor threshold assessment, and have been certified in AE management, seizure response, and basic life support (30).”
A Pragmatic Framework for Comparing TMS Treatment Schedules in Real-World Clinical Practice
Olmsted, A. M., Austelle, C. W., Lao, M., Sampair, I., Hack, L., Keller, C. J., & Yoon, J. H. (2026) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2026.100338
Hassanzadeh, S., Windebank, A. J., & Siddiqui, A. M. (2026) · Journal of Neurotrauma · doi:10.1177/08977151261497619
Metadata
- Authors
- McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., Krystal, A. D., Sampson, S. M., Morales, O., Nelson, B. G., Latoussakis, V., George, M. S., Lisanby, S. H., & on behalf of both the National Network of Depression Centers rTMS Task Group and the American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments
- Affiliations
- Duke University (US)
- Johns Hopkins University (US)
- Butler Hospital (US)
- Emory University (US)
- Weill Cornell Medicine (US)
- University of Michigan (US)
- University of California, Los Angeles (US)
- American Psychiatric Association (US)
- Mayo Clinic (US)
- Harvard University (US)
- University of Minnesota (US)
- Medical University of South Carolina (US)
- Corresponding author
- McClintock, Shawn M.
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2018-02-21
- Volume
- 79
- Issue
- 1
- Pages
- 35-48
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC5846193
- OpenAlex
- W2617605873
- Cited by
- 693
- References
- 120
- Citations by year
- 2026: 77 · 2025: 94 · 2024: 108 · 2023: 82 · 2022: 85 · 2021: 98 · 2020: 66 · 2019: 54 · 2018: 22
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR002384)
- National Institute of Mental Health (K23MH087739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- repetitive transcranial magnetic stimulation, major depressive disorder, depression treatment, expert consensus recommendations, antidepressant treatment
- MeSH terms
- Contraindications, Major Depressive Disorder, Humans, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.